FLGT Earnings

Quarterly EPS
$-0.48
Q3 2024
$-0.19
Q4 2024
$-0.37
Q1 2025
$-0.62
Q2 2025
$-0.21
Q3 2025
$-0.76
Q4 2025
$-0.80
Q1 2026
$-1.05
Q2 2026
Latest Revenue85.4M
Latest Net Income-29719000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.0585.4M-29719000+4.4%-69.4%
Q1 2026-$0.8071.1M-25274000-3.2%-116.2%
Q4 2025-$0.7683.3M-23650000+9.3%-300.0%
Q3 2025-$0.2184.1M-6826000+17.2%+56.3%
Q2 2025-$0.6281.8M-19256000+15.2%-113.8%
Q1 2025-$0.3773.5M-11899000+13.9%+17.8%
Q4 2024-$0.1976.2M-6190000+8.1%+95.6%
Q3 2024-$0.4871.7M-14694000-15.3%-9.1%
Q2 2024-$0.2971.0M-9090000
Q1 2024-$0.4564.5M-13846000
Q4 2023-$4.3070.5M-134334000
Q3 2023-$0.4484.7M-13466000
Fulgent Genetics (FLGT) — Earnings